STOCK TITAN

Upexi (UPXI) Stock News, Nov 2023-Jun 2024

UPXI NASDAQ

Upexi, Inc. reports developments for a Solana-focused digital asset treasury company that also owns consumer brands. Its updates center on acquiring and holding SOL, staking, discounted locked token purchases, capital issuance, and the consumer products business that develops, manufactures, and distributes branded goods.

Recurring news themes include quarterly financial results, digital asset revenue, share repurchase activity, financing transactions, registration matters, investor conference participation, and management communications about the company’s treasury strategy and capital allocation.

Rhea-AI Summary

On June 21, 2024, Upexi (NASDAQ:UPXI), a diversified Amazon and Direct-to-Consumer brand owner, updated shareholders on its delayed Form 10-Q filing for the period ending March 31, 2024. The company received a notice from Nasdaq on June 17, 2024, indicating a non-compliance with listing rules due to the missing report. Upexi has 60 days to submit a compliance plan, potentially extending up to December 11, 2024. However, Upexi aims to file the Form 10-Q by June 30, 2024, avoiding the need for a compliance plan. This notice does not affect the current listing or trading of Upexi's stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.88%
Tags
none
-
Rhea-AI Summary

On June 20, 2024, Upexi (NASDAQ: UPXI) announced a restructuring plan to reduce debt and increase working capital by selling assets. The company sold its wholly-owned subsidiary, VitaMedica, on June 13, 2024, which will help eliminate some existing debt and provide necessary working capital. Additionally, Upexi plans to sell a warehouse in Clearwater, Florida, by mid-July to further reduce debt by $2.6 million and generate $1.4 million in cash. CEO Allan Marshall emphasized that market conditions have made it difficult to raise growth capital, making asset sales the only viable option for debt reduction and future growth. Upexi will continue to assess strategic alternatives, which may include selling other business units. The company also plans to file its quarterly financial statements for the nine months ending March 31, 2024, on June 24, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.72%
Tags
none
-
Rhea-AI Summary

Upexi has completed its consolidation of operations, aiming to reduce annual operating expenses by $2-$3 million. This initiative is expected to have minimal impact on operations. The company is also exploring strategic alternatives to enhance shareholder value, including potential mergers, acquisitions, or asset sales. Upexi is engaging with an investment bank to assist in this process. Additionally, GBQ Partners has been appointed as the independent public accounting firm to audit the company's financial statements for fiscal years ending June 30, 2023, and 2024. There is no set timeline for the strategic review, and outcomes are not guaranteed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.75%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.02%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.13%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.71%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
conferences earnings date
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.69%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
conferences
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.31%
Tags
none

FAQ

What is the current stock price of Upexi (UPXI)?

Upexi (UPXI) last closed at $0.6416.

What is the market cap of Upexi (UPXI)?

The market cap of Upexi (UPXI) is approximately $57.0M.